[Remote] Medical Science Liaison (MSL), Oncology (Central) at BillionToOne

Remote

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Diagnostics, Healthcare, OncologyIndustries

Requirements

Candidates must possess an advanced degree in a related science or health discipline and have at least 2 years of experience as a Medical Science Liaison or in a similar oncology role, preferably with diagnostic experience. Expertise in discussing scientific content with diverse audiences and excellent communication and interpersonal skills are essential, along with the ability to travel up to 70%.

Responsibilities

The Medical Science Liaison will act as a key liaison to healthcare providers in oncology, focusing on liquid biopsy and BillionToOne products. They will build relationships with key opinion leaders through scientific exchange, support the commercial team with product information, and respond to customer inquiries with balanced clinical and scientific data. Responsibilities also include contributing to educational product development and adhering to regulatory and compliance requirements.

Skills

Oncology

Molecular Diagnostics

Liquid Biopsy

Medical Science Liaison

Scientific Exchange

Clinical Expertise

Key Opinion Leader (KOL) Engagement

HCP Engagement

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$380.2MTotal Funding

SERIES_DCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.

Rapid technological advancements may render their current technology obsolete.

Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.

Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.

They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.

Their new Austin facility will create 1,000 jobs, boosting production and local economy.

Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI

Try Jobo Free